Home > Insider Trading > Filing (0001127602-14-007031)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
850693	Allergan Inc	AGN	Pharmaceutical Preparations (2834)	951622442

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1190644	S Douglas Ingram	2525 Dupont Drive Irvine CA 92612	President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-02-14	84,000	$55.98	85,058	No	4	M	Direct
Common Stock	Disposition	2014-02-14	84,000	$124.40	1,058	No	4	S	Direct
Common Stock	Disposition	2014-02-14	13	$124.57	1,045	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	F	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2014-02-14	84,000	$0.00	84,000	$55.98

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2016-02-06	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,673	Indirect	By 401(k) Trust
Common Stock	3,612	Indirect	By Esop Trust
Common Stock	22,772	Indirect	By Family Trust

Footnotes

Includes shares acquired under the Allergan, Inc. Dividend Reinvestment Plan.
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $124.25 to $124.64, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.
Exempt disposition to the issuer, effective 2/14/2014, of a number of shares determined to be sufficient to satisfy tax withholding obligations resulting from the lapse of restrictions of an exempt award of 517 shares of restricted stock units granted on 2/17/2012.
Shares allocated to reporting person's SIP account as of reporting date.
Shares allocated to the reporting person's ESOP account as of reporting date.
Shares held by the Ingram Family Trust established September 16, 2003, of which the Reporting person and his spouse are each trustees.
The option becomes exercisable in four equal annual installments beginning February 6, 2007.